Liquid Biopsy Assay
Developed a launch strategy for a liquid biopsy assay, including a map of the current diagnostic paradigm, payer evidentiary thresholds, and barriers to use. Identified viable strategies to drive adoption, and developed a tactical market access action plan for the client to execute for a successful launch.
Developed a launch strategy for a liquid biopsy assay, including a map of the current diagnostic paradigm, payer evidentiary thresholds, and barriers to use. Identified viable strategies to drive adoption, and developed a tactical market access action plan for the client to execute for a successful launch.
CEO insights
Related articles
Real analysis from people who’ve been there
CMMI Engagement on CGT Model
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.